{"id":"https://openalex.org/W2053783728","doi":"https://doi.org/10.1177/0269881103017001716","title":"The pharmacovigilance of mirtazapine: results of a prescription event monitoring study on 13 554 patients in England","display_name":"The pharmacovigilance of mirtazapine: results of a prescription event monitoring study on 13 554 patients in England","alternate_titles":[],"publication_year":2003,"publication_date":"2003-01-01","ids":{"openalex":"https://openalex.org/W2053783728","doi":"https://doi.org/10.1177/0269881103017001716","mag":"2053783728","pmid":"https://pubmed.ncbi.nlm.nih.gov/12680749"},"language":"en","primary_location":{"id":"doi:10.1177/0269881103017001716","doi":"https://doi.org/10.1177/0269881103017001716","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0269881103017001716","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2053783728"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113225476","display_name":"Pipasha N. Biswas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140975","display_name":"Drug Safety Research Unit","ror":"https://ror.org/04a8rag37","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I4210140975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Pipasha N. Biswas","raw_affiliation_strings":["Drug Safety Research Unit, Bursledon Hall, Southampton, London, UK. pipasha.biswas@dsru.org","Drug Safety Research Unit, Bursledon Hall, Southampton, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety Research Unit, Bursledon Hall, Southampton, London, UK. pipasha.biswas@dsru.org","institution_ids":["https://openalex.org/I4210140975"]},{"raw_affiliation_string":"Drug Safety Research Unit, Bursledon Hall, Southampton, London, UK","institution_ids":["https://openalex.org/I4210140975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110054793","display_name":"Lynda Wilton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140975","display_name":"Drug Safety Research Unit","ror":"https://ror.org/04a8rag37","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I4210140975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Lynda V. Wilton","raw_affiliation_strings":["Drug Safety Research Unit, Bursledon Hall, Southampton"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety Research Unit, Bursledon Hall, Southampton","institution_ids":["https://openalex.org/I4210140975"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004126637","display_name":"Saad Shakir","orcid":"https://orcid.org/0000-0002-4084-297X","observed_orcids":["https://orcid.org/0000-0002-4084-297X"]},"institutions":[{"id":"https://openalex.org/I4210089966","display_name":"London School of Hygiene & Tropical Medicine","ror":"https://ror.org/00a0jsq62","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I4210089966"]},{"id":"https://openalex.org/I4210140975","display_name":"Drug Safety Research Unit","ror":"https://ror.org/04a8rag37","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I4210140975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Saad A. W. Shakir","raw_affiliation_strings":["Drug Safety Research Unit, Bursledon Hall, Southampton; London School of Hygiene and Tropical Medicine, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety Research Unit, Bursledon Hall, Southampton; London School of Hygiene and Tropical Medicine, London, UK","institution_ids":["https://openalex.org/I4210089966","https://openalex.org/I4210140975"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":4.6102,"has_fulltext":false,"cited_by_count":64,"citation_normalized_percentile":{"value":0.9446305,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"17","issue":"1","first_page":"121","last_page":"126"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10376","display_name":"Suicide and Self-Harm Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mirtazapine","display_name":"mirtazapine","score":1.0},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.8870000243186951},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.9710000157356262},{"id":"https://openalex.org/keywords/antidepressant-safety","display_name":"antidepressant safety","score":0.6039999723434448},{"id":"https://openalex.org/keywords/malaise","display_name":"malaise","score":0.7870000004768372},{"id":"https://openalex.org/keywords/agitation","display_name":"agitation","score":0.6510000228881836},{"id":"https://openalex.org/keywords/aggression","display_name":"aggression","score":0.6420000195503235},{"id":"https://openalex.org/keywords/liver-function-tests","display_name":"liver function tests","score":0.7459999918937683},{"id":"https://openalex.org/keywords/syncope","display_name":"syncope","score":0.6990000009536743},{"id":"https://openalex.org/keywords/facial-swelling","display_name":"facial swelling","score":0.7910000085830688},{"id":"https://openalex.org/keywords/primary-care-prescribing","display_name":"primary care prescribing","score":0.5049999952316284},{"id":"https://openalex.org/keywords/prescription-event-monitoring","display_name":"prescription-event monitoring","score":0.5139999985694885}],"concepts":[{"id":"https://openalex.org/C2781068410","wikidata":"https://www.wikidata.org/wiki/Q421930","display_name":"Mirtazapine","level":4,"score":0.8886970281600952},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.785922646522522},{"id":"https://openalex.org/C2779277585","wikidata":"https://www.wikidata.org/wiki/Q2673323","display_name":"Malaise","level":2,"score":0.6280753016471863},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.6258742809295654},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.6055762767791748},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.5368087887763977},{"id":"https://openalex.org/C2779426884","wikidata":"https://www.wikidata.org/wiki/Q407988","display_name":"Clonazepam","level":2,"score":0.46532532572746277},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.4299989342689514},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.4293104410171509},{"id":"https://openalex.org/C2780179036","wikidata":"https://www.wikidata.org/wiki/Q616181","display_name":"Serotonin syndrome","level":5,"score":0.42565932869911194},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.36993837356567383},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3475308418273926},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29918456077575684},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2644267678260803},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.18323993682861328},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.1387183964252472},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.10034546256065369},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C37000724","wikidata":"https://www.wikidata.org/wiki/Q50430226","display_name":"Serotonergic","level":4,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000078785","descriptor_name":"Mirtazapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000317","descriptor_name":"Adrenergic alpha-Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000317","descriptor_name":"Adrenergic alpha-Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000929","descriptor_name":"Antidepressive Agents, Tricyclic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000929","descriptor_name":"Antidepressive Agents, Tricyclic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D004739","descriptor_name":"England","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008803","descriptor_name":"Mianserin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D008803","descriptor_name":"Mianserin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D008803","descriptor_name":"Mianserin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011247","descriptor_name":"Pregnancy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011307","descriptor_name":"Drug Prescriptions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011358","descriptor_name":"Product Surveillance, Postmarketing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012702","descriptor_name":"Serotonin Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D012702","descriptor_name":"Serotonin Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/0269881103017001716","doi":"https://doi.org/10.1177/0269881103017001716","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0269881103017001716","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:12680749","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12680749","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of psychopharmacology (Oxford, England)","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W24957977","https://openalex.org/W78856436","https://openalex.org/W574940398","https://openalex.org/W1865247343","https://openalex.org/W1982479536","https://openalex.org/W1985505791","https://openalex.org/W2010786659","https://openalex.org/W2055421991","https://openalex.org/W2071214152","https://openalex.org/W2071942317","https://openalex.org/W2072379598","https://openalex.org/W2119571471","https://openalex.org/W2127153128","https://openalex.org/W2130422962","https://openalex.org/W3206486718"],"related_works":["https://openalex.org/W7017102010","https://openalex.org/W2055421991","https://openalex.org/W7134108420","https://openalex.org/W4417535458","https://openalex.org/W2129121334","https://openalex.org/W3140866175","https://openalex.org/W4406696697","https://openalex.org/W2143750129","https://openalex.org/W2522379335","https://openalex.org/W2115553707"],"abstract_inverted_index":{"Mirtazpine":[0],"is":[1],"the":[2,11,29,50,59,67],"first":[3,68],"noradrenaline":[4],"and":[5,36,47,57,83,101,127],"serotonin":[6],"specific":[7],"antidepressant.":[8],"We":[9],"monitored":[10],"safety":[12],"of":[13,70],"mirtazapine":[14,111],"as":[15],"reported":[16,116],"in":[17,20,66],"primary":[18],"practice":[19],"England.":[21],"The":[22],"exposure":[23],"data":[24],"were":[25,49,87,105,117],"provided":[26,43],"by":[27],"monitoring":[28],"dispensed":[30],"prescriptions":[31],"issued":[32],"between":[33],"September":[34],"1997":[35],"February":[37],"1999.":[38],"Questionnaires":[39],"sent":[40],"to":[41,110],"GPs":[42],"outcome":[44],"data.":[45],"Drowsiness/sedation":[46],"malaise/lassitude":[48],"most":[51],"frequent":[52],"ADRs":[53,115],"(116,":[54],"71":[55],"respectively)":[56],"had":[58],"highest":[60],"incidence":[61],"density":[62],"(per":[63],"1000":[64],"patient-months)":[65],"month":[69],"treatment":[71],"(58.1,":[72],"27.8":[73],"respectively).":[74],"Agitation":[75],"(73),":[76],"aggression":[77],"(70),":[78],"rash":[79],"(20),":[80],"hallucinations":[81],"(13)":[82],"abnormal":[84,91,98],"dreams":[85],"(31":[86],"unlabelled":[88],"AES":[89,107],"while":[90],"liver":[92],"function":[93],"tests":[94],"(12),":[95],"syncope":[96],"(8),":[97],"behaviour":[99],"(4)":[100],"visual":[102],"disturbance":[103],"(3)":[104],"labelled":[106],"possibly":[108],"due":[109],"use.":[112],"Serious":[113],"suspected":[114],"facial":[118],"oedema":[119],"(5),":[120],"allergy":[121],"(3),":[122],"bone":[123],"marrow":[124],"toxicity":[125],"(2)":[126],"myelodysplasia":[128],"(1).":[129]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2053783728","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
